Get the Stockscreener App
7.66
3.77%
-0.30
After Hours:
7.81
0.15
+1.96%
Avalo Therapeutics Inc Stock (AVTX) Latest News
(AVTX) Technical Data - Stock Traders Daily
Avalo Therapeutics to Present at Oppenheimer’s 35th Annual Healthcare Life Sciences Conference - GlobeNewswire
Avalo Therapeutics to Present at Oppenheimer's 35th Annual Healthcare Life Sciences Conference - The Manila Times
Avalo Therapeutics, Inc. (NASDAQ:AVTX) Short Interest Update - MarketBeat
Avalo Therapeutics, Inc. (NASDAQ:AVTX) Short Interest Up 176.2% in January - MarketBeat
(AVTX) Investment Report - Stock Traders Daily
When (AVTX) Moves Investors should Listen - Stock Traders Daily
AVTX (Avalo Therapeutics) Cash From Discontinued Investing Activities : $0.00 Mil (TTM As of Sep. 2024) - GuruFocus.com
Short Interest in Avalo Therapeutics, Inc. (NASDAQ:AVTX) Drops By 11.8% - MarketBeat
Avalo Therapeutics (NASDAQ:AVTX) Trading Up 6.5%Still a Buy? - MarketBeat
Avalo Therapeutics (NASDAQ:AVTX) Stock Price Up 6.5% – Still a Buy? - Defense World
(AVTX) Trading Signals - Stock Traders Daily
Avalo Therapeutics appoints first chief strategy officer - Pennsylvania Business Report
Avalo Therapeutics Appoints Jennifer Riley as Chief Strategy Officer - citybiz
Avalo Therapeutics Names Biogen Veteran Jennifer Riley as Chief Strategy Officer to Lead $10B Market Push - StockTitan
(AVTX) Proactive Strategies - Stock Traders Daily
Short Interest in Avalo Therapeutics, Inc. (NASDAQ:AVTX) Increases By 340.4% - MarketBeat
BTIG Research Begins Coverage on Avalo Therapeutics (NASDAQ:AVTX) - Defense World
Avalo Therapeutics initiated with a Buy at BTIG - Yahoo Finance
BTIG optimistic on Avalo Therapeutics stock with potential for transformative Phase 2b trial results - Investing.com Canada
(AVTX) Trading Report - Stock Traders Daily
LUCID CAPITAL MARKETS Initiates Coverage of Avalo Therapeutics (AVTX) with Buy Recommendation - MSN
Short Interest in Avalo Therapeutics, Inc. (NASDAQ:AVTX) Drops By 46.9% - MarketBeat
Avalo Therapeutics (AVTX) Is a Potential Hidden Gem with Significant Risk - TipRanks
Trading (AVTX) With Integrated Risk Controls - Stock Traders Daily
RA Capital Management L.P. Takes Position in Avalo Therapeutics, Inc. (NASDAQ:AVTX) - MarketBeat
Learn to Evaluate (AVTX) using the Charts - Stock Traders Daily
Avalo Therapeutics (FRA:C6K0) Cash From Other Investing Act - GuruFocus.com
Avalo Therapeutics (FRA:C6K0) Cyclically Adjusted PS Ratio : 0.02 (As of Nov. 21, 2024) - GuruFocus.com
REX American Resources Reports Upbeat Earnings, Joins Avalo Therapeutics, RH And Other Big Stocks Moving Higher On Thursday - MSN
(AVTX) Investment Analysis and Advice - Stock Traders Daily
Orbimed Advisors LLC Acquires New Stake in Avalo Therapeutics Inc - GuruFocus.com
Avalo Therapeutics director June Almenoff acquires $12,749 in stock - Investing.com
Avalo Therapeutics Inc (AVTX) Quarterly 10-Q Report - Quartzy
Avalo Therapeutics receives $69.4M in proceeds from full exercise of private placement warrants - MSN
Avalo Therapeutics secures $69.4 million from warrant exercise By Investing.com - Investing.com Australia
Avalo Therapeutics Closes $69.4 Million Financing - citybiz
Avalo Therapeutics receives $69.4M in proceeds from exercise of warrants - TipRanks
Avalo Therapeutics secures $69.4 million from warrant exercise - Investing.com India
Avalo Therapeutics Receives $69.4 Million in Proceeds from the Full Exercise of Private Placement Warrants - GlobeNewswire
Avalo Therapeutics Receives $69.4 Million in Proceeds from the Full Exercise of Private Placement Warrants - GlobeNewswire Inc.
Avalo Therapeutics to Present at Upcoming Investor Conferences - The Manila Times
Avalo Therapeutics reports Q3 EPS ($2.83) vs ($22.83) last year - TipRanks
Avalo Reports Third Quarter 2024 Financial Results and Recent Business Updates - GlobeNewswire
2.27%
5.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):